The RNAseq results provided additional support of the CD8 and granzyme B IHC data and suggested that Th1 response might be enhanced in the post-treatment tumor microenvironment due to up-regulation of IFNg and TBX21 gene expression. The gene discussed is IFNG; the disease is neoplasm.